tiprankstipranks
Genmab upgraded to Neutral from Underperform at Exane BNP Paribas
PremiumThe FlyGenmab upgraded to Neutral from Underperform at Exane BNP Paribas
10d ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
11d ago
Trump Trade: President advocates to close carried interest tax loophole
Premium
The Fly
Trump Trade: President advocates to close carried interest tax loophole
14d ago
Johnson & Johnson price target raised to $166 from $162 at Guggenheim
PremiumThe FlyJohnson & Johnson price target raised to $166 from $162 at Guggenheim
18d ago
Opening Day: Infinity Natural Resources valued at $1.3B in market debut
Premium
The Fly
Opening Day: Infinity Natural Resources valued at $1.3B in market debut
20d ago
European Commission authorizes Vocabria + Rekambys for HIV treatment
Premium
The Fly
European Commission authorizes Vocabria + Rekambys for HIV treatment
21d ago
Johnson & Johnson price target lowered to $165 from $170 at Raymond James
PremiumThe FlyJohnson & Johnson price target lowered to $165 from $170 at Raymond James
29d ago
Johnson & Johnson price target lowered to $155 from $170 at Stifel
Premium
The Fly
Johnson & Johnson price target lowered to $155 from $170 at Stifel
29d ago
Johnson & Johnson price target lowered to $159 from $160 at BofA
Premium
The Fly
Johnson & Johnson price target lowered to $159 from $160 at BofA
29d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100